- PRICING
- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
EN
A
RCUS
Arcus Bioscience
24.58
+1.15+4.91%Opening13:53 05/26 EDT
OPEN/PREV CLOSE23.32/23.43
TODAY RANGE23.07-24.86
VOL495.34K
MARKET CAP3.09B
52 WEEK RANGE7.91-28.72
AVG VOL (3M)1.20M
% TURNOVER0.39%
TURNOVER--
P/E (TTM)-7.7228
% RANGE7.64%
EPS(TTM)-3.1828
P/E(FORWARD)-6.7714
P/B5.89
BVPS4.175
DIVIDEND--
P/S12.47
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP2.18B
SHARES OUTSTANDING125.77M
NEXT EARNINGS08/04-08/10
FREE FLOAT88.80M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Dow Jones·05/18 15:17
Arcus Biosciences Coverage Assumed by Truist Securities at Buy
Benzinga·05/18 15:06
Truist Securities Assumes Arcus Biosciences at Buy, Raises Price Target to $35
TipRanks·05/18 10:36
Arcus Biosciences assumed with a Buy at Truist
Simply Wall St·05/16 13:59
Arcus Biosciences, Inc. (NYSE:RCUS) Analysts Just Trimmed Their Revenue Forecasts By 21%
Dow Jones·05/11 17:16
Arcus Biosciences Is Maintained at Equal-Weight by Morgan Stanley
Simply Wall St·05/09 21:31
Assessing Arcus Biosciences (RCUS) Valuation After Trial Discontinuations Collaboration Setback And Weak Q1 Results
Simply Wall St·05/08 13:58
Arcus Biosciences, Inc. (NYSE:RCUS) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates
Dow Jones·05/07 16:31
Arcus Biosciences Is Maintained at Buy by Goldman Sachs
Dow Jones·05/07 16:31
Arcus Biosciences Price Target Raised to $34.00/Share From $30.00 by Goldman Sachs
Benzinga·05/07 16:21
Goldman Sachs Maintains Buy on Arcus Biosciences, Raises Price Target to $34
Simply Wall St·05/07 12:36
Arcus Biosciences Q1 Loss Of US$128 Million Reinforces Bearish Profitability Concerns
TipRanks·05/07 11:09
Goldman Sachs Remains a Buy on Arcus Biosciences (RCUS)
Simply Wall St·05/06 10:23
Is It Too Late To Consider Arcus Biosciences (RCUS) After Its 221% One Year Surge?
Same Industry
Name/Symbol
Change%
Price